Advertisement
Co Presented By
Co Presented By

Jubilant Life receives USFDA nod for hypertension tablets

As on 30 June, 2016, Jubilant Life Sciences had a total of 770 filings for Oral Solids of which 578 have been approved in various regions globally

Advertisement
|Aug 24, 2016, 14:35:18 IST

New Delhi: Jubilant Life Sciences Wednesday said it has received approval from the US health regulator for Telmisartan Tablets, used for the treatment of hypertension, in the American market.Pharma1In a BSE filing, the company said "it has received Abbreviated New Drug Application (ANDA) final approval for Telmisartan Tablets, USP 20,40 and 80mg, the generic version of Micardis Tablets of Boehringer Ingelheim Pharmaceuticals Inc".As on 30 June, 2016, Jubilant Life Sciences had a total of 770 filings for Oral Solids of which 578 have been approved in various regions globally."This includes 70 ANDAs filed in the US, of which 44 have been approved and 104 filings in Europe," it said.

Handpicked stories, in your inbox
Global stories. Indian perspective. Zero noise.
No Spam. Unsubscribe Any Time.
First Published:Aug 24, 2016, 14:35:18 IST
Advertisement
Advertisement
Trending Stories

No premium queues, 30-minute target: What changes for Indian passport applicants in UAE

Indian passport applicants in the UAE can now access passport, visa and attestation services through Alhind’s 16 centres, with no premium queues, a Dh19 service fee and a target of completing applications within 30 minutes
4 min read
Advertisement
Advertisement
Up Next